These findings are significant for cachexia, as the sustained high levels of IL-6 in advanced cancer patients may interfere with the normal regulatory functions of IL-6 in managing glucose tolerance, fatty acid (FA) and amino acid metabolism, insulin action, and ultimately body mass [36]. The gene discussed is INS; the disease is cancer.